drugset / Trial / NCT01508676

Effects of Pennsaid on Clinical Neuropathic Pain

NCT01508676

Completed 35 enrolled Massachusetts General Hospital
RandomizedCrossoverQuadruple-blind

Summary

The purpose of this study is to see if the drug Pennsaid (Diclofenac) can help reduce pain felt by people with chronic nerve pain. The drug will be used 2-4 times each day for 2 weeks. The U.S. Food and Drug Administration (FDA) has approved Pennsaid to treat osteoarthritis (bone pain), but the FDA has not approved Pennsaid to treat neuropathic (nerve) pain. The research study will compare Pennsaid to placebo.

Timeline

Start
2011-11
Primary completion
2013-03
Completion
2016-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Diclofenac Other / unclassified Topical